What Role Now for Margetuximab in HER2 Breast Cancer? What Role Now for Margetuximab in HER2 Breast Cancer?

In the final report of a phase 3 trial, there was no overall survival advantage with margetuximab vs trastuzumab.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news